| | ENVIRONMENTAL HEALTH CRITERIA FOR BIOMARKERS IN RISK |
| | 1,19 | | MB | ASSESSMENT: VALIDITY AND VALIDATION |
| | 136 | | stron |
| | 3683 | | ID | World Health Organization |
| | 2006 | | rok |
| | CONTENTS |
| | PREAMBLE |
| | ABBREVIATIONS |
| | 1. INTRODUCTION |
| | 2. RISK ASSESSMENT |
| | 2.1 Hazard identification |
| | 2.2 Dose response |
| | 2.3 Exposure assessment for risk assessment |
| | 3. VALIDITY AND VALIDATION - GENERAL CONSIDERATIONS |
| | 4. VALIDATION OF SPECIFIC TYPES OF BIOMARKERS |
| | 4.1 Exposure biomarkers |
| | 4.2 Effect biomarkers |
| | 4.3 Susceptibility biomarkers |
| | 5. CROSS-SPECIES COMPARABILITY |
| | 6. NEW PERSPECTIVES |
| | 7. SUMMARY |
| | 8. CONCLUSIONS |
| | 9. RECOMMENDATIONS |
| | 9.1 General recommendations |
| | 9.2 Recommendations for future research |
| | 9.2.1 Prevalidation stage |
| | 9.2.2 Validation stage |
| | 9.3 Application |
| | REFERENCES |
| | APPENDIX I. BIOMARKERS OF EXPOSURE AND EFFECT FOR CARCINOGENICITY |
| | APPENDIX II. BIOMARKERS OF EXPOSURE AND EFFECT FOR NON-CARCINOGENIC END- |
| | POINTS |
| | APPENDIX III. MEASUREMENT OF DRUG METABOLIZING ENZYME POLYMORPHISMS AS |
| | INDICATORS OF SUSCEPTIBILITY |
| | APPENDIX IV. VALIDATION OF BIOMARKERS FOR ENVIRONMENTAL HEALTH RESEARCH |
| | AND RISK ASSESSMENT |
| | RESUME |